New cancer clinical trial: Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease

Published on: January 28, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share